A-82548A
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 2MZdQuLi7R0 |
|---|---|
| InChI | InChI=1S/C47H81NO14/c1-10-32(49)22-33-17-14-19-47(61-33)25-37-28(4)35(62-47)24-36-31(21-27(3)45(55)59-36)16-13-11-12-15-26(2)41(52)43(60-39-23-34(50)40(48(8)9)30(6)57-39)42(53)29(5)44(54)46(7,56)20-18-38(51)58-37/h13,16,18,20,26-37,39-45,49-50,52-56H,10-12,14-15,17,19,21-25H2,1-9H3/b16-13+,20-18+/t26-,27-,28+,29+,30-,31+,32-,33+,34-,35-,36-,37-,39-,40+,41-,42+,43+,44-,45?,46+,47+/m0/s1 |
| InChIKey | LFLPRACEAAMLQA-BNOOCXISSA-N |
| Mol Weight | 884.2 g/mol |
| Molecular Formula | C47H81NO14 |
| Exact Mass | 883.565706 g/mol |
| Enantiomer InChIKey | LFLPRACEAAMLQA-VIXRASCUSA-N |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
11-OXO-ONNAMIDE-A
7-BETA,8-ALPHA-DIANGELOYLOXYLONGIPIN-2-EN-1-ONE
6,7-DIHYDRO-11-OXO-ONNAMIDE-A
7-chloro-2-(methylthio)spiro[4H,5H-pyrano[3,4-e]-1,3-oxazine-5,2'(3'H)-benzoxazol]-4-one
SPIRAMYCIN-3
(2S(2-ALPHA(R),3A-ALPHA,4-BETA,7-BETA,7A-ALPHA))-(PHENYLMETHYL)-N-(2-(2-CHLORO-4,5-DI-(PHENYLMETHYL)-PHENYL)-2-((OCTAHYDRO-7,8,8-TRIMETHYL-4,7-MET
1-ALPHA,4-ALPHA-DIHYDROXY-9-ALPHA-ACETOXY-GUAIA-10(14),2-DIENE-12,6-ALPHA-OLIDE
6-O-METHYL-3-O-DECLADINOSYL-3-O-(4-NITROPHENYL)ACETYL-8A-AZA-8A-HOMOERYTHROMYCIN_A
#6;METHYL-3-O-(2,3,4,6-TETRA-O-ACETYL-BETA-D-GALACTOPYRANOSYL)-2-N-(2,3,4-TRI-O-ACETYL-ALPHA-L-RHAMNOPYRANOSYL)-ACETIMIDO-6-O-BENZYL-2-DEOXY-BETA-D-GLUCOPYRANO
6-O-METHYL-3-O-DECLADINOSYL-3-O-(4-METHOXYPHENYL)ACETAL-8A-AZA-8A-HOMOERYTHROMYCIN_A
| Title | Journal or Book | Year |
|---|---|---|
| Structure of the New Spiroketal-Macrolide A82548A. | The Journal of Antibiotics | 1995 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.